TapewireFind a company

organization · Reporting owner

STARR INTERNATIONAL CO INC

Disclosed activity across 1 company

Tapewire entity
104951
SEC CIK
0001236615

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Celularity IncCELU · Entity 714510% ownerMarch 01, 2022March 15, 2022

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Celularity Inc

Report date March 01, 2022 · Filed March 15, 2022

Jointly reported with Starr International Investments Ltd.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Class A Common StockSEC Table I · non-derivativeIndirectSee footnote15,281,389 Reported balance After 2022-03-01 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 1 · 2022-03-01 · Other · Acquired 6,640,694 · Balance 15,281,389

F1: The Issuer's securities are directly owned by Starr International Investments Ltd., a wholly-owned subsidiary of Starr International Company, Inc. By virtue of this relationship, Starr International Company, Inc. may be deemed to directly own such shares disclosed in this form.

Warrant (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.50IndirectSee footnote0 Reported balance After 2022-03-01 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2022-03-01 · Other · Disposed 6,640,694 · Balance 0

F2: The first to occur of: (a) March 16, 2025 or (b) the consummation of a Change of Control (as defined in the applicable warrant agreement) following March 1, 2022.

F1: The Issuer's securities are directly owned by Starr International Investments Ltd., a wholly-owned subsidiary of Starr International Company, Inc. By virtue of this relationship, Starr International Company, Inc. may be deemed to directly own such shares disclosed in this form.

Filing footnotes · ownership attribution and instrument terms

F1: The Issuer's securities are directly owned by Starr International Investments Ltd., a wholly-owned subsidiary of Starr International Company, Inc. By virtue of this relationship, Starr International Company, Inc. may be deemed to directly own such shares disclosed in this form.

F2: The first to occur of: (a) March 16, 2025 or (b) the consummation of a Change of Control (as defined in the applicable warrant agreement) following March 1, 2022.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
March 01, 2022 Filed Mar 15, 2022 17:40 UTC Celularity Inc CELU · Entity 7145 OtherWarrant (Right to Buy) · Derivative 6,640,694 $0.00 Strike: $3.50 $0.00
Disclosure

SEC source: 0001567619-22-006998 · doc1.xml · derivative · entry 2

STARR INTERNATIONAL CO INC · CIK 0001236615 · 10% owner

Starr International Investments Ltd. · CIK 0001480100 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 0

Underlying: Class A Common Stock · 6,640,694 shares

Expires not disclosed

F2 · derivative.expiration_date: The first to occur of: (a) March 16, 2025 or (b) the consummation of a Change of Control (as defined in the applicable warrant agreement) following March 1, 2022.

F1 · ownership.nature: The Issuer's securities are directly owned by Starr International Investments Ltd., a wholly-owned subsidiary of Starr International Company, Inc. By virtue of this relationship, Starr International Company, Inc. may be deemed to directly own such shares disclosed in this form.

Read SEC document
March 01, 2022 Filed Mar 15, 2022 17:40 UTC Celularity Inc CELU · Entity 7145 OtherClass A Common Stock 6,640,694 $3.50 $23,242,429.00
Disclosure

SEC source: 0001567619-22-006998 · doc1.xml · nonDerivative · entry 1

STARR INTERNATIONAL CO INC · CIK 0001236615 · 10% owner

Starr International Investments Ltd. · CIK 0001480100 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 15,281,389

F1 · ownership.nature: The Issuer's securities are directly owned by Starr International Investments Ltd., a wholly-owned subsidiary of Starr International Company, Inc. By virtue of this relationship, Starr International Company, Inc. may be deemed to directly own such shares disclosed in this form.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.